Search
Search Results
##search.searchResults.foundPlural##
-
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2995PDF: 1006HTML: 321 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3615PDF: 649HTML: 763 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2161PDF: 895HTML: 693 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2873PDF: 870HTML: 2338 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
992PDF: 589HTML: 264Suppl. Files: 370 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1962PDF: 984HTML: 1581 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2182PDF: 2059HTML: 816 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3961PDF: 1416HTML: 2205Fig.1: 317Fig. 2: 300 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
2171PDF: 1301HTML: 351 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2482PDF: 920HTML: 1713Figure 1: 288Table 1: 273 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2901PDF: 1038HTML: 624 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2786PDF: 1777HTML: 2478Table1: 321 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
2004PDF: 833HTML: 605 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2294PDF: 930HTML: 1662Figure 1: 635 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2771PDF: 1859HTML: 745 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8031PDF: 2553HTML: 2185Table 1.: 296Table 2.: 320Table 3.: 278Table 4.: 287 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1798PDF: 1002HTML: 3212Figure 5: 209Figure 4: 213Figure 3: 247Figure 1: 250Figure 2: 224 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1311PDF: 839HTML: 1561Figure 1: 299Figure 2: 330 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3984PDF: 1761HTML: 123 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3374PDF: 1723HTML: 414 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2675HTML: 375PDF: 999 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1693PDF: 1007Suppl. Files: 506HTML: 317 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
3409PDF: 1491HTML: 11884 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1805PDF: 837HTML: 1526







